Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Endoscopic colorectal cancer screening: a cost-saving analysis.

Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD.

J Natl Cancer Inst. 2000 Apr 5;92(7):557-63.

PMID:
10749911
2.

Cost-saving analysis of screening colonoscopy in Germany.

Sieg A, Brenner H.

Z Gastroenterol. 2007 Sep;45(9):945-51.

PMID:
17874356
3.

Estimates of costs and effects of screening for colorectal cancer in the United States.

Byers T, Gorsky R.

Cancer. 1992 Sep 1;70(5 Suppl):1288-95.

PMID:
1387342
4.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
5.
6.

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. doi: 10.1093/jnci/djp319. Epub 2009 Sep 24.

8.

Potential costs of flexible sigmoidoscopy-based colorectal cancer screening.

Marshall JR, Fay D, Lance P.

Gastroenterology. 1996 Dec;111(6):1411-7.

PMID:
8942718
9.
10.

Cost effectiveness of colorectal cancer screening in the elderly.

Wagner JL, Herdman RC, Wadhwa S.

Ann Intern Med. 1991 Nov 15;115(10):807-17.

PMID:
1929029
11.

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.

Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.

Ann Intern Med. 2001 Nov 6;135(9):769-81.

PMID:
11694102
12.

A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults.

Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB.

Int J Technol Assess Health Care. 2000 Summer;16(3):799-810.

PMID:
11028135
13.

Screening for colorectal cancer: the cost to find an advanced adenoma.

McGrath JS, Ponich TP, Gregor JC.

Am J Gastroenterol. 2002 Nov;97(11):2902-7.

PMID:
12425566
14.

Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK; PLCO Project Team.

J Natl Cancer Inst. 2005 Jul 6;97(13):989-97.

PMID:
15998952
15.
16.

Prevention of colorectal cancer. Costs and effectiveness of sigmoidoscopy.

Geul KW, Bosman FT, van Blankenstein M, Grobbee DE, Wilson JH.

Scand J Gastroenterol Suppl. 1997;223:79-87.

PMID:
9200311
17.

Colorectal cancer screening in Italy: feasibility and cost-effectiveness in a model area.

Sorrentino D, Paduano R, Bernardis V, Piccolo A, Bartoli E.

Eur J Gastroenterol Hepatol. 1999 Jun;11(6):655-60.

PMID:
10418938
18.
19.

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, Robinson MH, Logan RF.

Gut. 2001 Jul;49(1):91-6.

20.

What is the most cost-effective population-based cancer screening program for Chinese women?

Woo PP, Kim JJ, Leung GM.

J Clin Oncol. 2007 Feb 20;25(6):617-24.

PMID:
17308266

Supplemental Content

Support Center